ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,941Medicare Part D Prescriptions Filled, Including Refills

Rank: 239 out of 1677

$502K Total Retail Price of All Prescriptions

Rank: 363 out of 1677

518 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

14% of this provider’s 518 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 8,913 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 543 440 1 1
HYDROCODONE-ACETAMINOPHEN 503 415 S3 2 4
LISINOPRIL 480 393 3 3
LEVOTHYROXINE SODIUM 470 345 4 5
OMEPRAZOLE 455 330 5 6
METFORMIN HCL 332 246 6 7
METOPROLOL TARTRATE 268 217 7 12
FUROSEMIDE 246 198 8 8
AMLODIPINE BESYLATE 237 212 9 2
TRAMADOL HCL 234 165 10 16
CITALOPRAM HBR 228 167 11 22
HYDROCHLOROTHIAZIDE 219 192 12 9
GABAPENTIN 186 114 13 11
POTASSIUM CHLORIDE 178 142 14 14
CEPHALEXIN 165 122 15 99
ATENOLOL 145 108 16 21
PRAVASTATIN SODIUM 137 104 17 10
TRAZODONE HCL 133 107 18 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 127 94 19 17
METOPROLOL SUCCINATE 125 106 20 23
CRESTOR 123 64 21 28
LOVASTATIN 120 86 22 35
WARFARIN SODIUM 118 104 23 24
GLIPIZIDE 117 105 24 56
FAMOTIDINE 109 91 25 41
LANTUS 108 62 26 44
PROAIR HFA 107 92 27 50
FLUTICASONE PROPIONATE 105 60 28 29
SERTRALINE HCL 104 73 29 26
ALLOPURINOL 104 78 29 31
GLIPIZIDE ER 98 84 31 78
LOSARTAN POTASSIUM 94 86 32 25
FLUOXETINE HCL 89 61 33 49
RANITIDINE HCL 89 65 33 18
DOXAZOSIN MESYLATE 86 72 35 90
AMITRIPTYLINE HCL 85 65 R 36 63
CIPROFLOXACIN HCL 85 68 36 57
KLOR-CON 10 82 67 38 106
ZOLPIDEM TARTRATE 80 34 39 15
MELOXICAM 79 33 40 27
NEXIUM 79 55 40 19
ATORVASTATIN CALCIUM 76 65 42 13
TAMSULOSIN HCL 74 71 43 34
FENOFIBRATE 72 67 44 48
AZITHROMYCIN 71 58 45 38
ENALAPRIL MALEATE 70 70 46 82
ADVAIR DISKUS 69 48 47 54
CYCLOBENZAPRINE HCL 65 37 R 48 52
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 42 49 85
GLIPIZIDE XL 61 49 50 123
CLONIDINE HCL 59 25 51 36
CARISOPRODOL 58 35 R 52 68
ZETIA 58 52 52 75
ROPINIROLE HCL 57 50 54 79
DONEPEZIL HCL 55 55 55 30
VENTOLIN HFA 54 25 56 89
ALENDRONATE SODIUM 54 29 56 43
RISPERIDONE 54 15 56 60
LIPITOR 53 43 59 101
CLOPIDOGREL 53 39 59 32
VYTORIN 52 39 61 192
NAMENDA 52 52 61 39
CELEBREX 51 21 63 102
PAROXETINE HCL 50 31 64 67
ACTOS 50 42 64 104
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 20, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.